HSF Translational Research Grant Program (United States)

The Hidradenitis Suppurativa Foundation (HSF) invites applications for the Translational Research Grant Program, aimed at fostering innovative research in hidradenitis suppurativa (HS). This grant supports projects that may secure long-term funding from the National Institutes of Health or similar agencies. The application deadline is 7 December 2026. The HSF Translational Research Grant Program aims to stimulate and support new research projects in the field of hidradenitis suppurativa. The program is designed to aid researchers in developing projects that can later attract sustainable funding from larger institutions. The program focuses on translational research that shows relevance to HS, highlights innovation, and involves HS patients and caregivers in the study process. Projects should aim for rigorous research strategies and methodologies. This grant provides essential support to early-stage investigators working on HS, helping them to establish a foundation for future funding. By encouraging innovative and patient-inclusive research, the program seeks to advance understanding and treatment of HS, ultimately improving patient care. Who can apply for this grant? Only U.S.-based investigators eligible for grant applications at their host institutions can apply. What is the maximum funding available? Up to $100,000 per year in direct costs. What is the application deadline? The deadline is 7 December 2026. How will I be notified of the award decision? Notifications will be made in March 2027 at the AAD Annual Meeting. Can the grant cover indirect costs? No, the grant covers direct costs only. Interested applicants should review the detailed application guidelines and ensure all requirements are met by the deadline. For more information, applicants are encouraged to visit the official HSF website.